Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000729059 | SCV000856695 | uncertain significance | not provided | 2017-09-21 | criteria provided, single submitter | clinical testing | |
Athena Diagnostics | RCV000729059 | SCV001145149 | uncertain significance | not provided | 2023-08-30 | criteria provided, single submitter | clinical testing | Available data are insufficient to determine the clinical significance of the variant at this time. The frequency of this variant in the general population is uninformative in assessment of its pathogenicity (http://gnomad.broadinstitute.org). Computational tools yielded predictions that this variant is unlikely to have an effect on normal RNA splicing. |
Labcorp Genetics |
RCV001502376 | SCV001707209 | likely benign | Progressive sclerosing poliodystrophy | 2023-12-11 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003985810 | SCV004715089 | likely benign | POLG-related disorder | 2021-11-19 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |